Keeping up with health and wellness news from Comoros

Provided by AGP

Healthcare Brief Comoros: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Brief Comoros.

Press releases published on May 12, 2026

20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina
Adagene to Participate in Two Upcoming Investor Conferences
Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Proprietary N2B System May Offer Key to Unlocking Next-Gen Therapies
MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Leveraging AI, Voice Analysis to Develop Intoxication Detection
SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advancing a Differentiated Next-Gen GLP-1 Platform
Boehringer Ingelheim licenses preclinical antibody program from Immunitas Therapeutics to advance treatments for chronic inflammatory diseases
CRB Project Honored as 2026 ISPE Facility of the Year Awards Winner
FLYTE ACTIVATES HIGH-FREQUENCY PREAKNESS FLIGHT PROGRAM, DEPLOYING FLEET TO SERVE STRONG NORTHEAST DEMAND
IMUNON Reports First Quarter 2026 Financial Results and Provides Business Update
InVitria Presents New Data at ASGCT 2026 on Recombinant Human Serum Albumin for Higher Lentiviral Vector Titers and Improved Cell Therapy Manufacturing
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies
Ascentage Pharma to Participate in Three Upcoming Investor Conferences
PMV Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Highlights
Cloudbreak Pharma to Present at the Stifel 2026 Virtual Ophthalmology Forum
Solésence Reports First Quarter 2026 Financial Results
Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update
Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology
Cerevance Completes Enrollment in Pivotal Phase 3 Parkinson’s Disease Trial and Closes Oversubscribed $20 Million Series C to Extend Runway into 2027

Share us

on your social networks:

Sign up for:

Healthcare Brief Comoros

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.